Related Experiment Video
Updated: Jul 29, 2026

Th17 Inflammation Model of Oropharyngeal Candidiasis in Immunodeficient Mice
Published on: February 18, 2015
[Candida pneumonia in patients without definitive immunodeficiency]
Sabine Blaschke1, M Don, W Schillinger
1Abt. Nephrologie, Medizinische Universitätsklinik Göttingen, Deutschland.
Abstract:
The occurrence of community-acquired pneumonia due to yeast-like fungi of the genus Candida in patients without manifest immunodeficiency has previously been discounted. However, such pneumonias may indeed occur in patients with chronic parenchymal lung damage, e.g. from nicotine. Candida pneumonia can be triggered in these patients for example by trivial viral infections. Three corresponding cases are discussed.
Insights
Community-acquired pneumonia from Candida yeast can occur in individuals without weakened immune systems, particularly those with chronic lung damage from factors like smoking. These infections may be triggered by common viral illnesses.
Area of Science:
- Medical Mycology
- Pulmonology
- Infectious Diseases
Background:
- Community-acquired pneumonia (CAP) is typically attributed to bacterial or viral pathogens.
- Infections caused by yeast-like fungi, specifically Candida species, are often dismissed in patients lacking overt immunodeficiency.
Observation:
- This study highlights the potential for Candida pneumonia in patients with pre-existing chronic lung conditions, such as those resulting from smoking.
- The research suggests that minor viral infections can act as a trigger for Candida pneumonia in susceptible individuals.
Findings:
- Three cases are presented demonstrating Candida pneumonia in patients without known immunodeficiency but with chronic lung damage.
- These findings challenge the traditional view that Candida pneumonia exclusively affects immunocompromised individuals.
Implications:
- Clinicians should consider Candida pneumonia in the differential diagnosis of pneumonia, especially in patients with risk factors like chronic lung disease and smoking history.
- Further research is warranted to understand the pathogenesis and optimize treatment strategies for Candida pneumonia in non-immunocompromised populations.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis
Candidiasis
Pneumonia I: Introduction

